Sort   by:  
 Page size 
UnknownThe Nonstructural NS1 Protein of Influenza Viruses Modulates TP53 Splicing through Host Factor CPSF4.
Not available
S-EPMC6430556 | biostudies-literature
UnknownInfluenza A viruses alter the stability and antiviral contribution of host E3-ubiquitin ligase Mdm2 during the time-course of infection.
Not available
S-EPMC5829072 | biostudies-literature
UnknownNucleolin interacts with influenza A nucleoprotein and contributes to viral ribonucleoprotein complexes nuclear trafficking and efficient influenza viral replication.
Not available
S-EPMC4931502 | biostudies-literature
UnknownCharacterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia.
Not available
S-EPMC7373044 | biostudies-literature
UnknownCharacterization of cellular transcriptomic signatures induced by different respiratory viruses in human reconstituted airway epithelia.
Not available
S-EPMC6685967 | biostudies-literature
UnknownHuman Respiratory Syncytial Virus-Induced Immune Signature of Infection Revealed by Transcriptome Analysis of Clinical Pediatric Nasopharyngeal Swab Samples.
Not available
S-EPMC8006426 | biostudies-literature
UnknownTranscriptional Profiling of Immune and Inflammatory Responses in the Context of SARS-CoV-2 Fungal Superinfection in a Human Airway Epithelial Model.
Not available
S-EPMC7764715 | biostudies-literature
UnknownAvian Cell Line DuckCelt®-T17 Is an Efficient Production System for Live-Attenuated Human Metapneumovirus Vaccine Candidate Metavac®.
Not available
S-EPMC8540687 | biostudies-literature
UnknownMucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice.
Not available
S-EPMC11187144 | biostudies-literature
UnknownEarly nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs.
Not available
S-EPMC8352718 | biostudies-literature
Sort   by:  
 Page size